Vibegron News

← Back to News Overview

---

Vibegron currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Vibegron with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Original indication: Obgemsa is indicated in symptomatic treatment of adult patients with overactive bladder (OAB) syndrome.
• Evidence level: L5
• Predicted indications (20):
  • overactive bladder (disease) (95.9%)
  • polycystic kidney disease 3 with or without polycystic liver disease (94.5%)
  • mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies (94.5%)
  • renal-hepatic-pancreatic dysplasia (92.5%)
  • Joubert syndrome with renal defect (91.5%)
  • thoracic malformation (91.3%)
  • esophageal varices with bleeding (91.3%)
  • esophageal varices without bleeding (91.3%)
  • karyomegalic interstitial nephritis (90.3%)
  • adult familial nephronophthisis-spastic quadriparesia syndrome (90.2%)
  • hypotrichosis simplex of the scalp (90.0%)
  • 16q24.1 microdeletion syndrome (89.0%)
  • congenital hypotrichosis milia (88.4%)
  • primary interstitial lung disease specific to childhood (88.4%)
  • isolated pulmonary capillaritis (88.0%)
  • congenital pulmonary lymphangiectasia (86.3%)
  • psychogenic movement disorders (85.6%)
  • chronic tic disorder (84.6%)
  • tremor-nystagmus-duodenal ulcer syndrome (84.1%)
  • primary orthostatic tremor (84.0%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.